{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:38:38Z","timestamp":1787315918055,"version":"build-2736575974"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005285","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Goi\u00e1s","doi-asserted-by":"publisher","award":["Call 6\/2020"],"award-info":[{"award-number":["Call 6\/2020"]}],"id":[{"id":"10.13039\/501100005285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Since angiotensin-converting enzyme 2, ACE2, was identified as the receptor for SARS-CoV-2 and considering the intense physiological interplay between the two angitensinases isoforms, ACE and ACE2, as counter-regulatory axis of the renin-angiotensin system, we proposed the evaluation of polymorphisms in these two key regulators in relation to COVID-19 severity. A genetic association study involving 621 COVID-19 hospitalized patients from Brazil was performed. All subjects had a confirmed diagnosis of COVID-19 via RT-PCR. Patients were categorized into two groups: the \"mild\" group (N = 296), composed of individuals hospitalized in ward beds who progressed to cure, and the \"severe\" group (N = 325), composed of individuals who required hospitalization in an intensive care unit (ICU), or who died. Blood samples were genotyped for ACE I\/D polymorphism and ACE2 G8790A polymorphism by real-time PCR via TaqMan assay. The analysis of combined polymorphisms revealed a protective role for genotypic profile II\/A_ (OR\n                    <jats:sup>A<\/jats:sup>\n                    = 0,26; p = 0,037) against the worsening of COVID-19 in women. The results indicate a protection profile to COVID-19 progression, in which the II\/A_ carriers have almost four times less chance of a severe outcome. It is proposed that a decreased activity of ACE (deleterious effects) in conjunction with an increased ACE2 activity (protective effects), should be the underlying mechanism. The findings are unprecedented once other studies have not explored the genotypic combination analysis for ACE and ACE2 polymorphisms and bring perspectives and expectations for dealing with the COVID-19 pandemic based on definitions of genetically-based risk groups within the context of personalized medicine.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0288178","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T13:31:58Z","timestamp":1701351118000},"page":"e0288178","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combinatorial analysis of ACE and ACE2 polymorphisms reveals protection against COVID-19 worsening: A genetic association study in Brazilian patients"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5913-712X","authenticated-orcid":true,"given":"Romes Bittencourt Nogueira de","family":"Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis Raquel Silva do","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique Alves","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Rafaela Milhomem Cruz","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton Luiz","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel de","family":"Deus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina Silva","family":"Rebelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7405-6822","authenticated-orcid":true,"given":"Denise da Silva","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0488-5400","authenticated-orcid":true,"given":"Gustavo Rodrigues","family":"Pedrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"pone.0288178.ref001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"C Huang","year":"2020","journal-title":"China. The Lancet"},{"key":"pone.0288178.ref002","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"R Lu","year":"2020","journal-title":"The Lancet"},{"key":"pone.0288178.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02520-8","article-title":"Pathophysiology and treatment strategies for COVID-19.","volume":"18","author":"M Kumar","year":"2020","journal-title":"J Transl Med"},{"key":"pone.0288178.ref004","doi-asserted-by":"crossref","first-page":"104502","DOI":"10.1016\/j.meegid.2020.104502","article-title":"From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses","volume":"85","author":"N Kirtipal","year":"2020","journal-title":"Infection, Genetics and Evolution"},{"key":"pone.0288178.ref005","first-page":"94","article-title":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS","author":"Y Wan","year":"2020","journal-title":"J Virol"},{"key":"pone.0288178.ref006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fddsv.2021.789710","article-title":"Is Covid-19 Severity Associated With ACE2 Degradation?","volume":"1","author":"U Bastolla","year":"2022","journal-title":"Frontiers in Drug Discovery."},{"key":"pone.0288178.ref007","first-page":"854","article-title":"Downregulation of ACE2 induces overstimulation of the renin\u2013angiotensin system in COVID-19: should we block the renin\u2013angiotensin system?","volume":"43","author":"F Silhol","year":"2020","journal-title":"Hypertension Research 2020 43:8."},{"key":"pone.0288178.ref008","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1042\/CS20201493","article-title":"ACE2, a multifunctional protein\u2013from cardiovascular regulation to COVID-19","volume":"134","author":"M Bader","year":"2020","journal-title":"Clin Sci"},{"key":"pone.0288178.ref009","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"I Hamming","year":"2004","journal-title":"Journal of Pathology"},{"key":"pone.0288178.ref010","first-page":"302","article-title":"[Lessons from SARS: a new potential therapy for acute respiratory distress syndrome (ARDS) with angiotensin converting enzyme 2 (ACE2)].","volume":"57","author":"Y Imai","year":"2008","journal-title":"Masui."},{"key":"pone.0288178.ref011","first-page":"543","article-title":"The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice","author":"Y Imai","year":"2008","journal-title":"Experimental Physiology. Blackwell Publishing Ltd"},{"key":"pone.0288178.ref012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"P Verdecchia","year":"2020","journal-title":"Eur J Intern Med"},{"key":"pone.0288178.ref013","first-page":"67","article-title":"The Duplicitous Nature of ACE2 in COVID-19 Disease.","author":"SN Heyman","year":"2021","journal-title":"EBioMedicine"},{"key":"pone.0288178.ref014","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3389\/fphys.2020.574753","article-title":"ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle.","volume":"11","author":"Z Abassi","year":"2020","journal-title":"Front Physiol."},{"key":"pone.0288178.ref015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases","author":"K Kuba","year":"2006","journal-title":"Current Opinion in Pharmacology. Elsevier"},{"key":"pone.0288178.ref016","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1042\/CS20200899","article-title":"ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV","volume":"134","author":"L Lubbe","year":"2020","journal-title":"Clin Sci"},{"key":"pone.0288178.ref017","first-page":"NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China.","author":"W Guan","year":"2020","journal-title":"New England Journal of Medicine."},{"key":"pone.0288178.ref018","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"X Li","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"pone.0288178.ref019","doi-asserted-by":"crossref","first-page":"e2029058","DOI":"10.1001\/jamanetworkopen.2020.29058","article-title":"Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19","volume":"3","author":"N Rosenthal","year":"2020","journal-title":"JAMA Netw Open"},{"key":"pone.0288178.ref020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.11613\/BM.2009.004","article-title":"Pleiotropic effects of ACE polymorphism.","author":"SK Nawaz","year":"2009","journal-title":"Biochem Med (Zagreb)."},{"key":"pone.0288178.ref021","article-title":"Not just angiotensinases: New roles for the angiotensin-converting enzymes","author":"DW Lambert","year":"2010","journal-title":"Cellular and Molecular Life Sciences"},{"key":"pone.0288178.ref022","doi-asserted-by":"crossref","first-page":"e0221248","DOI":"10.1371\/journal.pone.0221248","article-title":"The combination of ACE I\/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients","volume":"14","author":"DS Pinheiro","year":"2019","journal-title":"PLoS One"},{"key":"pone.0288178.ref023","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/nar\/20.6.1433-a","article-title":"PCR detection of the insertion\/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).","volume":"20","author":"B Rigat","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"pone.0288178.ref024","first-page":"197","article-title":"Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.","volume":"51","author":"L Tiret","year":"1992","journal-title":"Am J Hum Genet"},{"key":"pone.0288178.ref025","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"B Rigat","year":"1990","journal-title":"J Clin Invest"},{"key":"pone.0288178.ref026","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/320104","article-title":"Linkage and Association Analysis of Angiotensin I\u2013Converting Enzyme (ACE)\u2013Gene Polymorphisms with ACE Concentration and Blood Pressure.","volume":"68","author":"X Zhu","year":"2001","journal-title":"The American Journal of Human Genetics"},{"key":"pone.0288178.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2014.00227","article-title":"From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension.","volume":"5","author":"SK Patel","year":"2014","journal-title":"Front Physiol."},{"key":"pone.0288178.ref028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/CS20120269","article-title":"The ACE2 gene: its potential as a functional candidate for cardiovascular disease","volume":"124","author":"LM Burrell","year":"2013","journal-title":"Clin Sci (Lond)."},{"key":"pone.0288178.ref029","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11906-000-0057-4","article-title":"Hypertension and Single Nucleotide Polymorphisms.","volume":"2","author":"MJ Rieder","year":"2000","journal-title":"Current Hypertension Reports Current Science Inc ISSN"},{"key":"pone.0288178.ref030","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3389\/fgene.2020.564741","article-title":"Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India.","volume":"11","author":"A Srivastava","year":"2020","journal-title":"Front Genet."},{"key":"pone.0288178.ref031","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/FPC.0000000000000436","article-title":"ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19","author":"B M\u00f6hlendick","year":"2021","journal-title":"Pharmacogenet Genomics"},{"key":"pone.0288178.ref032","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1002\/jmv.27160","article-title":"Polymorphisms of ACE (I\/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.","volume":"93","author":"S Karaka\u015f \u00c7elik","year":"2021","journal-title":"J Med Virol"},{"key":"pone.0288178.ref033","first-page":"315","article-title":"SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves","author":"LCJ Alcantara","year":"2022","journal-title":"Virus Res"},{"key":"pone.0288178.ref034","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1373\/clinchem.2005.051656","article-title":"Genotyping of the Angiotensin I-Converting Enzyme Gene Insertion\/Deletion Polymorphism by the TaqMan Method","volume":"51","author":"W Koch","year":"2005","journal-title":"Clin Chem"},{"key":"pone.0288178.ref035","article-title":"The host\u2019s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections","author":"JR Delanghe","year":"2020","journal-title":"Clinica Chimica Acta"},{"key":"pone.0288178.ref036","article-title":"COVID-19 infections are also affected by human ACE1 D\/I polymorphism.","author":"JR Delanghe","year":"2020","journal-title":"Clinical Chemistry and Laboratory Medicine. De Gruyter"},{"key":"pone.0288178.ref037","doi-asserted-by":"crossref","first-page":"00940","DOI":"10.1183\/23120541.00940-2020","article-title":"Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium.","volume":"7","author":"M Jacobs","year":"2021","journal-title":"ERJ Open Res."},{"key":"pone.0288178.ref038","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"L Fang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"pone.0288178.ref039","doi-asserted-by":"crossref","first-page":"e0248580","DOI":"10.1371\/journal.pone.0248580","article-title":"On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database.","volume":"16","author":"de Souza FSH","year":"2021","journal-title":"PLoS One."},{"key":"pone.0288178.ref040","doi-asserted-by":"crossref","first-page":"e0234452","DOI":"10.1371\/journal.pone.0234452","article-title":"Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain","volume":"15","author":"S Iftimie","year":"2020","journal-title":"PLoS One."},{"key":"pone.0288178.ref041","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/all.14657","article-title":"Risk factors for severe and critically ill COVID-19 patients: A review","volume":"76","author":"Gao Y dong","year":"2021","journal-title":"Allergy"},{"key":"pone.0288178.ref042","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbrc.2004.05.114","article-title":"Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor","volume":"319","author":"H Hofmann","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"pone.0288178.ref043","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"M Hoffmann","year":"2020","journal-title":"Cell"},{"key":"pone.0288178.ref044","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1042\/CS20200901","article-title":"Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease","volume":"134","author":"CM Ferrario","year":"2020","journal-title":"Clin Sci"},{"key":"pone.0288178.ref045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21873\/invivo.12672","article-title":"The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19","volume":"36","author":"I Gintoni","year":"2022","journal-title":"In Vivo (Brooklyn)."},{"key":"pone.0288178.ref046","article-title":"The ACE2 G8790A Polymorphism: Involvement in Type 2 Diabetes Mellitus Combined with Cerebral Stroke.","author":"YH Wu","year":"2017","journal-title":"J Clin Lab Anal"},{"key":"pone.0288178.ref047","doi-asserted-by":"crossref","first-page":"e0243887","DOI":"10.1371\/journal.pone.0243887","article-title":"ACE2 polymorphisms as potential players in COVID-19 outcome.","volume":"15","author":"AS Khayat","year":"2020","journal-title":"PLoS One"},{"key":"pone.0288178.ref048","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40618-020-01383-6","article-title":"Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome","volume":"44","author":"C Foresta","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"pone.0288178.ref049","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/cbf.3648","article-title":"Genetic and epigenetic control of ACE2 expression and its possible role in COVID\u201019","volume":"39","author":"RS Lima","year":"2021","journal-title":"Cell Biochem Funct"},{"key":"pone.0288178.ref050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12020-020-02381-7","article-title":"Worldwide ACE (I\/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression.","volume":"68","author":"N Hatami","year":"2020","journal-title":"Endocrine"},{"key":"pone.0288178.ref051","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2147\/CIA.S261516","article-title":"COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients.","volume":"15","author":"J Sie\u0144ko","year":"2020","journal-title":"Clin Interv Aging."},{"key":"pone.0288178.ref052","doi-asserted-by":"crossref","first-page":"144944","DOI":"10.1016\/j.gene.2020.144944","article-title":"SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I\/D genotype","volume":"758","author":"N Yamamoto","year":"2020","journal-title":"Gene"},{"key":"pone.0288178.ref053","doi-asserted-by":"crossref","first-page":"105161","DOI":"10.1016\/j.earlhumdev.2020.105161","article-title":"Understanding COVID-19: A hypothesis regarding digit ratio (2D:4D), ACE I\/D polymorphism, oxygen metabolism and national case fatality rates.","volume":"151","author":"JT Manning","year":"2020","journal-title":"Early Hum Dev"},{"key":"pone.0288178.ref054","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jinf.2020.11.012","article-title":"Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.","volume":"81","author":"AK Aung","year":"2020","journal-title":"Journal of Infection."},{"key":"pone.0288178.ref055","first-page":"1","article-title":"Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.","volume":"4","author":"K Suryamohan","year":"2021","journal-title":"Communications Biology 2021 4:1."},{"key":"pone.0288178.ref056","first-page":"1","article-title":"Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review","volume":"27","author":"J Li","year":"2022","journal-title":"Eur J Med Res"},{"key":"pone.0288178.ref057","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3389\/fgene.2020.551220","article-title":"Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome.","volume":"11","author":"AE Shikov","year":"2020","journal-title":"Front Genet."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T13:32:22Z","timestamp":1701351142000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288178"}},"subtitle":[],"editor":[{"given":"Jun","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":57,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0288178","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]}}}